Sunday, September 20, 2026
ExploreSearch
Via News
Markets

Ulta Beauty Stock Over 3% Down So Far On Friday

ViaNews Editorial Team

December 4, 2020

Ulta Beauty Stock Over 3% Down So Far On Friday
Shares of Ulta Beauty slid 3.95% to $278.09 at 14:08 EST on Friday, after three consecutive sessions in a row of gains. The Nasdaq Stock Market is rising 0.56% to $12,446.80, following yesterday's upward trend, on what so far seems, a somewhat positive trend trading session today.

Ulta Beauty's Sales

Ulta Beauty's sales growth is a negative 11.1% for the current quarter and 40.5% for the next. The company's growth estimates for the current quarter is a negative 36% and positive 260.4% for the next.

Ulta Beauty's Revenue

Year-on-year quarterly revenue growth declined by 0%, now sitting on for the twelve trailing months.

Categories

Markets

Tags

Stock MarketStockWall StreetStock PriceStock Market NowNASDAQMarket SessionIXICThe Nasdaq Stock MarketULTAStock Price DownUlta Beauty
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com